AMRX earnings call for the period ending September 30, 2020.
News & Analysis: Amneal Pharmaceuticals, Inc.
AMRX earnings call for the period ending June 30, 2020.
AMRX earnings call for the period ending March 31, 2020.
Regulators take different approaches to the unapproved medications.
Healthcare bargain hunters can find good values in quality low-priced stocks.
The company expects to produce around 20 million tablets within a month.
No, but doctors can still use the drugs despite limited evidence of their effectiveness.
The online pharmacy conducted its own tests of the type-2 diabetes drug and found excessive levels of a carcinogenic compound in 42% of the batches it tested.
AMRX earnings call for the period ending December 31, 2019.
The generic drug company announced the approval and launch of an important new product.